Try our Advanced Search for more refined results
October 14, 2013
Savient Pharmaceuticals, Inc., et al.,
Case Number:
1:13-bk-12680
Court:
Nature of Suit:
Firms
- Ashby & Geddes
- ASK LLP
- Buchalter APC
- Cole Schotz
- Dilworth Paxson
- Faegre Drinker
- Fox Rothschild
- Frost Brown
- Gellert Scali
- GrayRobinson
- Hunton Andrews
- Kirkland & Ellis
- Klehr Harrison
- Landis Rath
- Maslon LLP
- McCarter & English
- Norton Rose
- Pachulski Stang
- Paul Weiss
- Richards Layton
- Robinson & Cole
- Skadden Arps
- Stroock & Stroock
- White and Williams
- Young Conaway
Companies
- Crealta Pharmaceuticals LLC
- Epiq Systems Inc.
- Fujifilm
- Iron Mountain Inc.
- Lazard Ltd.
- Level 3 Communications Inc.
- McKesson Corp.
- Mesirow Financial Holdings Inc.
- Microsoft Corp.
- Savient Pharmaceuticals Inc.
- The PNC Financial Services Group Inc.
- U.S. Bancorp
- Wolters Kluwer
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 19, 2014
Bankrupt Savient Wins Approval For Ch. 11 Plan
A Delaware bankruptcy judge on Monday blessed Savient Pharmaceuticals Inc.'s Chapter 11 liquidation plan, allowing the estate of the former drug developer to distribute $120 million in sale proceeds and other remaining assets among its creditors.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login